Treatment of Fungal Nail Infections
Terbinafine 250 mg daily is the first-line treatment for dermatophyte onychomycosis: 6 weeks for fingernails and 12 weeks (up to 16 weeks) for toenails. 1, 2
Essential Pre-Treatment Requirements
Do not initiate treatment without mycological confirmation of infection through microscopy and culture. 1 This critical step prevents unnecessary treatment, as other conditions like psoriasis and nail trauma can mimic fungal infection. 3
First-Line Systemic Treatment: Terbinafine
Terbinafine is superior to all other antifungal agents for dermatophyte onychomycosis both in vitro and in vivo, making it the preferred first-line choice. 1
Dosing Regimen
- Fingernail infections: 250 mg daily for 6 weeks 1
- Toenail infections: 250 mg daily for 12-16 weeks 1, 2, 4
- Can be taken with or without food 5
Expected Outcomes
- Cure rates of 80-90% for fingernails and 70-80% for toenails 1
- Re-evaluate patients 3-6 months after treatment initiation 2
- Full nail regrowth may take up to 18 months for toenails 1
Mechanism and Superiority
Terbinafine inhibits squalene epoxidase, resulting in both fungistatic (ergosterol depletion) and fungicidal (squalene accumulation) effects. 1 Its minimum inhibitory concentration (MIC) is approximately 0.004 µg/mL, equivalent to its minimal fungicidal concentration, confirming true fungicidal activity. 1
Monitoring Requirements
- Baseline liver function tests (LFTs) and complete blood count are recommended 1, 2, 5
- More vigilant monitoring needed in patients with:
Common Adverse Effects
- Headache, gastrointestinal upset, and taste disturbance 1, 4, 5
- Taste changes usually improve within weeks after stopping but may become permanent 5
- Can aggravate psoriasis and cause subacute lupus-like syndrome 1
Serious but Rare Adverse Effects
- Hepatotoxicity requiring liver transplant or causing death 5
- Stevens-Johnson syndrome and toxic epidermal necrolysis 4
- Depressive symptoms 5
Drug Interactions
Terbinafine has minimal drug interactions compared to azole antifungals, making it particularly useful in immunocompromised patients on multiple medications. 2, 6 The main concern is with drugs metabolized by cytochrome P450 2D6. 2
Second-Line Systemic Treatment: Itraconazole
Itraconazole is the next best alternative when terbinafine cannot be used. 1 It is less effective than terbinafine for dermatophytes but is the most effective agent for Candida nail infections. 1
Dosing Options
Two regimens are available:
- Continuous therapy: 200 mg daily for 12 weeks 1
- Pulse therapy: 400 mg daily for 1 week per month
Candida Onychomycosis
For Candida nail plate invasion, use the same pulse regimen: 400 mg daily for 1 week per month, repeated for 2 months (fingernails) or 3-4 pulses (toenails). 1
Important Considerations
- Must be taken with food and requires acidic pH for optimal absorption 1
- Contraindicated in heart failure 1
- Potent CYP3A4 inhibitor with significant drug interaction potential 6
- Monitor hepatic function in patients with pre-existing abnormalities or receiving continuous therapy >1 month 1
Third-Line Option: Fluconazole
Fluconazole may be useful when patients cannot tolerate terbinafine or itraconazole. 1, 4
- Dosing: 150-450 mg weekly for 3 months (fingernails) or at least 6 months (toenails) 1, 4
- Contraindicated in hepatic and renal impairment 1
Topical Treatments
Topical therapy is inferior to systemic treatment except in very distal infections or superficial white onychomycosis. 1
When to Consider Topical Treatment
- Mild cases with limited nail involvement 4
- As adjunctive therapy to systemic treatment 4
- Patients who cannot tolerate systemic therapy 4
Available Options
- Amorolfine nail lacquer: Applied once or twice weekly 4
- Ciclopirox 8% nail lacquer: Applied daily for up to 48 weeks; mycological cure rates approach 50% 4, 3
- Efinaconazole 10%: Applied daily; mycological cure rates approach 50% 4
Treatment of Yeast Infections
Most yeast infections associated with paronychia can be treated topically. 1
- Apply broad-spectrum, colorless, non-sensitizing antiseptics to the proximal nail 1
- Alternate imidazole lotion with antibacterial lotion 1
- Continue until cuticle integrity is restored (may take several months) 1
Managing Treatment Failure
Despite terbinafine being the most effective agent, a consistent 20-30% failure rate occurs. 1
Common Causes of Failure
- Poor compliance 1
- Presence of dermatophytoma (dense white lesion of tightly packed hyphae beneath the nail) 1
- Nail thickness >2 mm 1
- Severe onycholysis 1
- Slow nail outgrowth 1
Management of Dermatophytoma
Partial or complete nail removal is indicated before retreatment when dermatophytoma is present, as this tightly packed fungal mass prevents adequate drug penetration. 1 Cure rates approaching 100% can be achieved with nail avulsion under ring block prior to treatment. 1
Prevention of Recurrence
Recurrence is common due to ubiquitous environmental exposure to T. rubrum in public facilities. 1
Essential Preventive Measures
- Always wear protective footwear in public bathing facilities, gyms, and hotel rooms 1
- Apply absorbent antifungal powders (miconazole, clotrimazole, or tolnaftate) in shoes and on feet 1
- Wear cotton, absorbent socks 1
- Keep nails as short as possible 1
- Avoid sharing toenail clippers 1
- Discard old, moldy footwear or disinfect with naphthalene mothballs in sealed plastic bags for minimum 3 days 1
- Treat all infected family members simultaneously 1
Critical Pitfalls to Avoid
- Never treat without mycological confirmation - other conditions frequently mimic onychomycosis 1
- Do not use griseofulvin as first-line therapy - it has poor cure rates, high relapse rates, and requires prolonged treatment (often >1 year) 1, 7, 8
- Recognize that culture of yeasts and non-dermatophyte molds requires careful interpretation - yeasts are often secondary infections and non-dermatophyte molds are frequently saprophytic in previously damaged nails 1
- Do not expect immediate results - allow at least 48-72 weeks from treatment start to assess true efficacy and identify relapse 1
- Monitor for photosensitivity with terbinafine - advise patients to minimize exposure to natural and artificial sunlight 5